This article was automatically generated by Dow Jones using technology from Automated Insights.

The following companies are among those expected to report their latest financial results before the market opens.

Ciena Corp.'s first-quarter EPS is forecast at 60 cents, compared with 6 cents in the prior-year period. Adjusted EPS is forecast at $1.17.

Kroger Co.'s fourth-quarter EPS is forecast at $1.20, compared with 90 cents in the prior-year period.

Burlington Stores Inc.'s fourth-quarter EPS is forecast at $4.75, compared with $4.02 in the prior-year period. Adjusted EPS is forecast at $4.76.

BJ's Wholesale Club Holdings Inc.'s fourth-quarter EPS is forecast at 92 cents, compared with 92 cents in the prior-year period. Adjusted EPS is forecast at 93 cents.

Toro Co.'s first-quarter EPS is forecast at 64 cents, compared with 52 cents in the prior-year period. Adjusted EPS is forecast at 65 cents.

Victoria's Secret & Co.'s fourth-quarter EPS is forecast at $2.49, compared with $2.33 in the prior-year period. Adjusted EPS is forecast at $2.52.

John Wiley & Sons Inc.'s third-quarter EPS is forecast at 67 cents. Adjusted EPS is forecast at 86 cents.

Tango Therapeutics Inc.'s fourth-quarter EPS is forecast at a loss of 30 cents, compared with a loss of 35 cents in the prior-year period. Adjusted EPS is forecast at a loss of 32 cents.

Distribution Solutions Group Inc.'s fourth-quarter EPS is forecast at 19 cents, compared with a loss of 55 cents in the prior-year period.

Olaplex Holdings Inc.'s fourth-quarter EPS is forecast at a loss of 2 cents, compared with a loss of 1 cent in the prior-year period. Adjusted EPS is forecast at 1 cent.

Myers Industries Inc.'s fourth-quarter EPS is forecast at 23 cents, compared with 11 cents in the prior-year period.

Stratasys Ltd.'s fourth-quarter EPS is forecast at a loss of 23 cents, compared with a loss of 59 cents in the prior-year period. Adjusted EPS is forecast at 6 cents.

Kura Oncology Inc.'s fourth-quarter EPS is forecast at a loss of 64 cents, compared with a loss of 22 cents in the prior-year period.

Bioventus Inc.'s fourth-quarter EPS is forecast at 12 cents. Adjusted EPS is forecast at 22 cents.

CorMedix Inc.'s fourth-quarter EPS is forecast at 67 cents, compared with 22 cents in the prior-year period. Adjusted EPS is forecast at 82 cents.

Generated from Dow Jones Calendar Live with data from Dow Jones and Factset.

(END) Dow Jones Newswires

March 05, 2026 05:30 ET (10:30 GMT)

Copyright (c) 2026 Dow Jones & Company, Inc.